Michael Sela

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Monkbot (talk | contribs) at 15:12, 8 January 2021 (Task 18 (cosmetic): eval 6 templates: del empty params (1×); hyphenate params (6×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Michael Sela
מיכאל סלע
Michael Sela
Born
Mieczysław Salomonowicz

(1924-03-02) March 2, 1924 (age 100)
Tomaszów Mazowiecki, Poland
Nationality (legal)Israeli
Occupationimmunologist
Known for
TitleW. Garfield Weston Professor of Immunology at the Weizmann Institute of Science
Awards

Michael Sela (Hebrew: מיכאל סלע; born Mieczysław Salomonowicz; 2 March 1924) is an Israeli immunologist of Polish Jewish origin. He is the W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science in Rehovot.[1] He is a former President of the Weizmann Institute of Science.

Birth and academic career

Michael Sela was born as Mieczysław Salomonowicz in Tomaszów Mazowiecki, Poland, in 1924.[2][3] In 1935 when he was 11 years old he and his family moved to Romania.[2][4] In 1941 when he was 17 years old he and his family made aliya and immigrated to Mandatory Palestine.[2][5] He studied at the Hebrew University of Jerusalem (M.Sc., Chemistry, 1946; Ph.D., 1954).[6]

Today, he is Professor in the Weizmann Institute's Immunology Department. He is a former President of the Weizmann Institute of Science, from 1975-1985.[7]

Research

Sela is known for his research in immunology, particularly for research on synthetic antigens, molecules that trigger the immune system to attack. This work of Sela has led to the discovery of the genetic control of the immune response, as well as to the design of vaccines based on synthetic molecules.

He was among the first who introduced the use of linear and branched synthetic polypeptides as antigens, and this brought about a better understanding of immunological phenomena.

For several decades, Sela has been interested in the possibility of fighting the autoimmune disease, experimental allergic encephalomyelitis (EAE) with synthetic analogs of the molecules in the myelin sheath of the brain which are capable of provoking the disease.

He is probably best known as the co-developer (with Ruth Arnon and Dvora Teitelbaum) of the multiple sclerosis drug copaxone.

Awards and honours

Sela has received several awards. Following are the major awards received by Sela.

See also

References

  1. ^ Michael Sela at the Weizmann Institute of Science
  2. ^ a b c "Oral History Project - Michael Sela". In.bgu.ac.il. Retrieved 2020-02-21.
  3. ^ USA (2019-05-06). "Isolation and Characterization of Antibodies: the Work of Michael Sela". The Journal of Biological Chemistry. 285 (39). Ncbi.nlm.nih.gov: e12–e14. doi:10.1074/jbc.O110.000235. PMC 2943276.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  4. ^ "Historical perspective: An interview with renowned Immunologist Dr. Michael Sela "
  5. ^ "Prof. Michael Sela | Still hard at work, pursuing the understanding of immunology | WeizmannCompass". Weizmann.ac.il. 2017-06-04. Retrieved 2020-02-21.
  6. ^ "Probing into the realm of proteins and immunity "
  7. ^ "Prof. Michael Sela | Still hard at work, pursuing the understanding of immunology | WeizmannCompass". Weizmann.ac.il. 2017-06-04. Retrieved 2020-02-10.
  8. ^ "Israel Prize recipients in 1959 (in Hebrew)". Israel Prize Official Site. Archived from the original on February 17, 2010.
  9. ^ "Otto-Warburg-Medal". GBM. Archived from the original on 7 January 2019. Retrieved 12 January 2014.
  10. ^ Membrii Academiei Române
  11. ^ The Wolf Prize in Medicine Archived 2009-02-26 at the Wayback Machine

External links

Retrieved from "https://en.wikipedia.org/w/index.php?title=Michael_Sela&oldid=999111053"